Copley Scientific

Activities: Regulatory Analysis

Leading manufacturer and supplier of pharmaceutical testing equipment

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Training & Education

Registration opens for the Copley Inhaler Testing Academy

It offers attendees an opportunity to improve their understanding of regulatory guidance, testing fundamentals and the application of core methods in the OINDP industry
Manufacturing

Manufacturing Chemist Webinar Roundtables Series - Oral Dosage Manufacturing

5 March 2024 | Webinar | 15:00 GMT
Training & Education

Copley 2024: the webinar series on OINDP testing

Begins on the 28th February 2024 and offers valuable insights for researchers and analysts looking to improve orally inhaled and nasal drug product (OINDP) testing practice
Manufacturing

New literature from Copley provides guidance for better inhaler testing

New literature from Copley Scientific, the world’s leading manufacturer and supplier of inhaled product testing equipment, highlights the importance of controlling temperature, relative humidity (RH) and electrostatics in the test environment to maximise the integrity and value of inhaler test data
Manufacturing

New IPAC-RS paper offers insight and guidance for testing aqueous nasal inhalation products

This new paper adds to the information available to the growing number of people seeking to capitalise on the intrinsic benefits of intranasal drug delivery
Manufacturing

Copley introduces Patient Exhalation Simulator to help inhaler developers understand the impact of poor patient technique

The new Patient Exhalation Simulator (PES) allows investigators to simulate this misuse condition via the controlled and realistic delivery of warm, humid air into a DPI prior to routine tests to evaluate drug delivery performance
Manufacturing

Copley appoints new Business Development Manager

Imran Haneef is set to take up the role and will focus exclusively on the solid dose, semisolid, transdermal, and powder testing portfolio
Subscribe now